Powerful, Liposomal Palmitoylethanolamide using Levagen+

Palmitoylethanolamide (PEA) is a fatty acid amide naturally produced in the human body. It is derived from palmitic acid and ethanolamine. PEA is classified as a “endocannabinoid-like” compound because it interacts with the body’s endocannabinoid system, which plays a role in regulating various physiological functions, including pain and inflammation. In this respect, it can be considered as a similar compound to CBD.

PEA has garnered significant interest for its potential anti-inflammatory and analgesic (pain-relieving) properties. Some studies have suggested that PEA may help in managing chronic pain conditions, such as neuropathic pain, fibromyalgia, and certain types of inflammation. It is believed to work by modulating the activity of certain receptors and pathways in the body that are involved in pain and inflammation.

PEA is available as a food supplement and is sometimes used for these potential therapeutic purposes, although its effectiveness and appropriate usage can vary from person to person.